Stentys says CE Mark approval in the European Union for its Xposition S stent came ahead of schedule.
Stentys this week said it won a CE Mark ahead of schedule for its latest self-apposing coronary stent, a product that will be used with delivery system technology it acquired last June.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1IsmksM
Cap comentari:
Publica un comentari a l'entrada